3-AP in Treating Patients With Advanced or Metastatic Solid Tumors

Summary

This phase I trial is studying the side effects and best dose of 3-AP in treating patients with advanced or metastatic solid tumors. 3-AP may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Timeline

Start

2006-12

Primary completion

2011-02

Completion

—

Drugs

Indications